{"symbol":"CHRS","name":"Coherus Oncology, Inc.","sector":"Healthcare","industry":"Biotechnology","currency":"USD","reportedCurrency":"USD","asOf":{"dataUpdatedAt":"2026-10-06T10:11:28.447Z","note":"lastClose is the verified official regular-session close; latestPrice is a regular-session quote and may be delayed. Fundamentals are trailing-twelve-month unless suffixed otherwise."},"price":{"lastClose":1.12,"lastCloseDate":"2026-10-05","latestPrice":1.0709,"priceSource":"fmp-delayed","change":-0.049100000000000144,"changePercent":-4.383928571428584,"marketCap":165455071,"high52Week":2.62,"low52Week":1.08,"returnYtdPercent":-21.13,"return1YPercent":-31.71},"valuation":{"peRatio":null,"peRatioForward":null,"psRatio":3.25,"pbRatio":2.72,"pfcfRatio":null,"pegRatio":null,"evToEbitda":null,"evToSales":2.36,"earningsYieldPercent":null,"fcfYieldPercent":null},"profitability":{"grossMarginPercent":63.55,"operatingMarginPercent":-425.72,"netMarginPercent":-257.1,"roePercent":-215.26,"roaPercent":-68.5,"roicPercent":-135.38},"financialHealth":{"currentRatio":1.77,"quickRatio":1.7,"debtToEquity":0.62,"interestCoverage":-19.95},"dividends":{"yieldPercent":null,"payoutRatioPercent":null,"dividendPerShare":null,"consecutiveYears":0},"growthCagrPercent":{"revenue":{"y3":-34.57,"y5":-33.6,"y10":1.52},"grossProfit":{"y3":-29.08,"y5":-37.88,"y10":null},"netIncome":{"y3":null,"y5":null,"y10":null},"eps":{"y3":null,"y5":null,"y10":null},"freeCashFlow":{"y3":null,"y5":null,"y10":null},"dividends":{"y3":null,"y5":null,"y10":null},"totalReturn":{"y3":-31.4,"y5":-41.38,"y10":-26.92}},"links":{"overview":"https://tgmcharts.com/stocks/CHRS","metrics":"https://tgmcharts.com/stocks/CHRS/metrics","financials":"https://tgmcharts.com/stocks/CHRS/financials","docs":"https://tgmcharts.com/llms.txt"},"applicability":{"freeCashFlow":"applicable","enterpriseValue":"applicable","earnings":"applicable"},"classification":{"type":"operating","flags":{"adr":false,"foreignFiler":false,"semiannualReporter":false,"fund":false}}}